Request Demo
Last update 15 Jul 2025
Alprostadil liposome(CSPC Zhongqi)
Last update 15 Jul 2025
Overview
Basic Info
Drug Type Small molecule drug, Liposomal Drug |
Synonyms- |
Target |
Action agonists |
Mechanism EP1 agonists(Prostanoid EP1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
3
Clinical Trials associated with Alprostadil liposome(CSPC Zhongqi)NCT05475717
A Multicenter, Randomized, Open-label Phase II Clinical Trial Evaluating Alprostadil Liposomal Injection in the Prevention of Contrast-induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention
NCT04197323
Alprostadil Liposomes for Injection for Lower Extremity Arteriosclerosis Obliteran of Phase II Clinical Trial
NCT03669562
The Safety, Tolerability and Pharmacokinetic Phrase I Study of Alprostadil Fat Emulsiom Injection in Healthy Adult Volunteers
100 Clinical Results associated with Alprostadil liposome(CSPC Zhongqi)
Login to view more data
100 Translational Medicine associated with Alprostadil liposome(CSPC Zhongqi)
Login to view more data
100 Patents (Medical) associated with Alprostadil liposome(CSPC Zhongqi)
Login to view more data
100 Deals associated with Alprostadil liposome(CSPC Zhongqi)
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Kidney Injury | Phase 2 | China | 20 Oct 2022 | |
| Peripheral Arterial Disease | Phase 2 | China | 01 Oct 2019 | |
| Arteriosclerosis Obliterans | Phase 2 | China | 30 Sep 2019 | |
| Rest pain | Phase 2 | China | 30 Sep 2019 | |
| Arterial Occlusive Diseases | Phase 1 | China | 07 Aug 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free